Figures
- FIGURE 1
Prevalence and change in the total number of symptoms during the infection and after 3 and 6 months of follow-up. The width of lines is proportional to the flow rate.
- FIGURE 2
Prevalence of symptoms during the infection and after 3 and 6 months of follow-up. HR: heart rate; BW: body weight.
- FIGURE 3
Self-reported health status before the infection and after 3 and 6 months of follow-up. The width of lines is proportional to the flow rate.
- FIGURE 4
Post-coronavirus disease 2019 functional status scale after 3 and 6 months of follow-up. The width of lines is proportional to the flow rate.
- FIGURE 5
Problems on the 5-level EuroQol-5 Dimensions version domains after 3 and 6 months of follow-up.
Tables
- TABLE 1
Characteristics and outcomes of patients with confirmed coronavirus disease 2019 (COVID-19) diagnosis
Subjects n 239 Women 198 (82.8) Age years 50.0 (39.0–56.0) BMI kg·m−2 26.0 (23.4–30.5) Married/living with partner 173 (72.4) Pre-existing comorbidities 0 142 (59.4) 1 62 (25.9) ≥2 35 (14.6) Health status before infection Good 208 (87.0) Moderate 28 (11.7) Poor 3 (1.3) Time between T0 and completion questionnaire weeks T1 10.4±2.4 T2 22.6±2.4 Number of symptoms T0 15 (11–18) T1 6 (4–9)* T2 6 (3–8)*,# Work productivity and activity index Percentage of work time missed due to ill health (absenteeism) T1 72.9±35.2 T2 52.4±38.4# Percentage of impairment while working (presenteeism) T1 66.1±25.8 T2 59.7±24.0# Overall work impairment due to health (work productivity) T1 89.3±19.4 T2 78.6±26.0# Activity impairment T1 71.4±21.7 T2 59.7±22.8# Self-reported poor health T0 1.3 T1 25.5* T2 10.5*# Post-COVID-19 functional status scale Grade T1 2.4±0.9 T2 2.2±1.0# Quality of life EQ-5D index T1 0.645±0.181 T2 0.694±0.165# EQ-5D index<P5 reference values [23] T1 36.8 T2 26.8# Today's health status (VAS 0–100) points T1 49±19 T2 56±18# Received care Physiotherapy Between T0 and T1 31.8 Between T1 and T2 61.9# Rehabilitation Between T0 and T1 4.2 Between T1 and T2 11.7# Need for help with personal care From partner Before 5.0 Between T0 and T1 46.0* Between T1 and T2 21.3*,# From family Before 1.7 Between T0 and T1 17.2* Between T1 and T2 7.1*,# Data are presented as n (%), median (interquartile range), mean±sd or %, unless otherwise stated. BMI: body mass index; T0: symptom onset; T1: first questionnaire; T2: second questionnaire; P5: percentile five; VAS: visual analogue scale. *: p<0.05 versus before; #: p<0.05 versus T1.
Supplementary Material
Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.
Supplementary material 0141-2021_Supplementary_Material
Supplementary figure 1 0141-2021_Supplementary_Figure_1
Supplementary figure 2 0141-2021_Supplementary_Figure_2
Supplementary figure 3 0141-2021_Supplementary_Figure_3
Supplementary figure 4 0141-2021_Supplementary_Figure_4
Supplementary figure 5a 0141-2021_Supplementary_Figure_5a
Supplementary figure 5b 0141-2021_Supplementary_Figure_5b
Supplementary figure 5c 0141-2021_Supplementary_Figure_5c
